Convegni | ARCO – ONLUS | Attività Ricerca Clinica Oncologica

Tissue Factor Pathway Inhibitor 2 (TFPI2) methylated DNA is a sensitive and specific serum biomarker of metastatic melanoma

Posted on 17 dicembre 2014

Lo Nigro C, Wang H, Lattanzio L, Matin R, Harwood C, Syed N, Occelli M, Merlano M, Evans A, Thompson A, Leigh I, Fleming C, Proby C, Crook T: “Tissue Factor Pathway Inhibitor 2 (TFPI2) methylated DNA is a sensitive and specific serum biomarker of metastatic melanoma”, XVIII Annual Meeting of IMI (Italian Melanoma Intergroup), […]

A friendly, cheap and very sensitive method for k-Ras point mutations detection based on PNA-directed PCR-clamping in metastatic colorectal carcinoma

Posted on

Messa F, Bracco E, Millo E, Tornissi F, Ungari S, Lattanzio L, Merlano M, Damonte G, Lo Nigro C: “A friendly, cheap and very sensitive method for k-Ras point mutations detection based on PNA-directed PCR-clamping in metastatic colorectal carcinoma”, 54 Congresso Nazionale della Società Italiana di Cancerologia (SIC), Bologna, 1-4 ottobre 2012.

Differential molecular mechanism of the docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells

Posted on

Lattanzio L, Tonissi F, Monteverde M, Milano G, Merlano M, Lo Nigro C: “Differential molecular mechanism of the docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells”, 54 Congresso Nazionale della Società Italiana di Cancerologia (SIC), Bologna, 1-4 ottobre 2012.

A demethylation screen identifies zinc finger protein 655/Vav-interacting kinase (Vik-1) as a novel putative tumour suppressor gene in lung cancer

Posted on

O’Leary K, Cavicchioli F, Shia A, Haley V, Comino A, Wischnewsky MB, Crook T, Lo Nigro C, Schmid P: “A demethylation screen identifies zinc finger protein 655/Vav-interacting kinase (Vik-1) as a novel putative tumour suppressor gene in lung cancer”, The European Association for Cancer Research (EACR-22), Barcellona, 7-10 luglio 2012.

Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients

Posted on

Merlano M, Monteverde M, Strola G, Barriere J, Etienne-Grimaldi MC, Miraglio E, Lattanzio L, Vivenza D, Messa F, Lo Nigro C, Milano G: “Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients”, ASCO Annual Meeting, Chicago, 1-5 giugno 2012.

Allelic distribution of aldosteron-syntase receptor in a congestive heart failure Caucasian population

Posted on

Feola M, Mussapi F, Crosetto N, Vivenza D, Lo Nigro C, Vado A: “Allelic distribution of aldosteron-syntase receptor in a congestive heart failure Caucasian population”, Heart Failure Congress 2012, Belgrado, Germania, 19-22 maggio 2012.

NT5E promoter methylation is a favourable breast cancer epigenetic biomarker

Posted on

Lo Nigro C, Monteverde M, Lee S, Lattanzio L, Syed N, Garrone O, Merlano M, Hatzimichael E, Briasoulis E, Thompson A, Crook T: “NT5E promoter methylation is a favourable breast cancer epigenetic biomarker”, 103rd AACR Annual Meeting, Orlando (FL), USA, 31 marzo-4 aprile 2012.

Polimorfismi nei geni del sistema renina-angiotensina-aldosterone e cardiotossicità dopo chemioterapia con antracicline nel carcinoma mammario

Posted on

Vivenza D, Corsetto N, Feola M, Garrone O, Monteverde M, Bobbio M, Merlano M, Lo Nigro C: “Polimorfismi nei geni del sistema renina-angiotensina-aldosterone e cardiotossicità dopo chemioterapia con antracicline nel carcinoma mammario”, XIV Congresso Nazionale Società Italiana Genetica Umana (SIGU), Milano, 13-16 novembre 2011.

Alta frequenza di mutazioni complesse in p53 in metastasi del SNC nel tumore al seno

Posted on

Lo Nigro C, Vivenza D, Palmieri C, Monteverde M, Lattanzio L, Gojis O, Garrone O, Merlano M, Quinlan P, Syed N, Thompson A, Crook T: “Alta frequenza di mutazioni complesse in p53 in metastasi del SNC nel tumore al seno”, XIV Congresso Nazionale Società Italiana Genetica Umana (SIGU), Milano, 13-16 novembre 2011.

MDM2 309 single nucleotide polymorphisms (SNP) and clinical outcome in patients with advanced squamous cell carcinoma of head and neck (SCCHN)

Posted on

Vivenza D, Gasco M, Natoli G, Monteverde M, Lattanzio L, Colantonio I, Miraglio E, Comino A, Syed N, Crook T, Merlano M, Lo Nigro C: “MDM2 309 single nucleotide polymorphisms (SNP) and clinical outcome in patients with advanced squamous cell carcinoma of head and neck (SCCHN)”, XIII Congresso Nazionale AIOM, Bologna, 5-7 novembre 2011.